We report the use of dexmedetomidine infusion in critically ill infants and children at doses of 0.2–0.7 μg/kg/hr for a median duration of 141 hours. The major findings from our study include 1) ...
Please provide your email address to receive an email when new articles are posted on . Altering the combined doses of dexmedetomidine and propofol impacts mortality risk in patients aged 65 years or ...
Dexmedetomidine may be renoprotective by reducing ischemia-reperfusion injury, according to the investigators. Dexmedetomidine may reduce the odds of delayed graft function following ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, ...
NEW HAVEN, Conn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved two sizes of dexmedetomidine hydrochloride injection for sedation purposes in ICU patients ...
Patients who received dexmedetomidine for greater than or equal to 72 hours numbered 114. After excluding 16 patients (14 had dexmedetomidine paused during the 72 hours, and two patients for whom we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results